Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergi Mas

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Schizophrenia Research|June 6, 2022
Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohortÀlex G Segura, Albert Martínez-Pinteño, Patricia Gassó, et al.
Reproductive Biomedicine Online|July 3, 2023
First babies conceived with Automated Intracytoplasmic Sperm InjectionNuno Costa-Borges, Santiago Munné, Eduard Albó, et al.
Journal of Psychopharmacology (Oxford, England)|February 4, 2020
Association study of candidate genes with obesity and metabolic traits in antipsychotic-treated patients with first-episode psychosis over a 2-year periodPatricia Gassó, Joan Albert Arnaiz, Sergi Mas, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 4, 2024
Polygenic risk scores mediating functioning outcomes through cognitive and clinical features in youth at family risk and controlsAlex G Segura, Elena de la Serna, Gisela Sugranyes, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 13, 2026
Corrigendum to "Polygenic risk scores mediating functioning outcomes through cognitive and clinical features in youth at family risk and controls" [European Neuropsychopharmacology 81 (2024) 28-37]Alex G Segura, Elena de la Serna, Gisela Sugranyes, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 25, 2024
Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approachGustavo J Gil-Berrozpe, Alex G Segura, Ana M Sánchez-Torres, et al.
Acta Psychiatrica Scandinavica|December 26, 2024
From Genetics to Psychosocial Functioning: Unraveling the Mediating Roles of Cognitive Reserve, Cognition, and Negative Symptoms in First-Episode PsychosisM Florencia Forte, Derek Clougher, Àlex G Segura, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 26, 2022
The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal studyAlbert Martínez-Pinteño, Gisela Mezquida, Miquel Bioque, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|June 16, 2022
Genetic and Structural Brain Correlates of Cognitive Subtypes Across Youth at Family Risk for Schizophrenia and Bipolar DisorderIsabel Valli, Elena De la Serna, Alex G Segura, et al.
Schizophrenia (Heidelberg, Germany)|July 19, 2022
Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patientsNatalia Rodríguez, Patricia Gassó, Albert Martínez-Pinteño, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Schizophrenia Research|June 6, 2022
Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohortÀlex G Segura, Albert Martínez-Pinteño, Patricia Gassó, et al.
Reproductive Biomedicine Online|July 3, 2023
First babies conceived with Automated Intracytoplasmic Sperm InjectionNuno Costa-Borges, Santiago Munné, Eduard Albó, et al.
Journal of Psychopharmacology (Oxford, England)|February 4, 2020
Association study of candidate genes with obesity and metabolic traits in antipsychotic-treated patients with first-episode psychosis over a 2-year periodPatricia Gassó, Joan Albert Arnaiz, Sergi Mas, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 4, 2024
Polygenic risk scores mediating functioning outcomes through cognitive and clinical features in youth at family risk and controlsAlex G Segura, Elena de la Serna, Gisela Sugranyes, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 13, 2026
Corrigendum to "Polygenic risk scores mediating functioning outcomes through cognitive and clinical features in youth at family risk and controls" [European Neuropsychopharmacology 81 (2024) 28-37]Alex G Segura, Elena de la Serna, Gisela Sugranyes, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 25, 2024
Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approachGustavo J Gil-Berrozpe, Alex G Segura, Ana M Sánchez-Torres, et al.
Acta Psychiatrica Scandinavica|December 26, 2024
From Genetics to Psychosocial Functioning: Unraveling the Mediating Roles of Cognitive Reserve, Cognition, and Negative Symptoms in First-Episode PsychosisM Florencia Forte, Derek Clougher, Àlex G Segura, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 26, 2022
The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal studyAlbert Martínez-Pinteño, Gisela Mezquida, Miquel Bioque, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|June 16, 2022
Genetic and Structural Brain Correlates of Cognitive Subtypes Across Youth at Family Risk for Schizophrenia and Bipolar DisorderIsabel Valli, Elena De la Serna, Alex G Segura, et al.
Schizophrenia (Heidelberg, Germany)|July 19, 2022
Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patientsNatalia Rodríguez, Patricia Gassó, Albert Martínez-Pinteño, et al.
Pageof 11